Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney

Human Molecular Genetics

Volumn 13, Issue 18, 2004, Pages 2061-2074

  Anglesio, Michael S ^a   Evdokimova, Valentina ^a   Melnyk, Nataliya ^a   Zhang, Liyong ^b   Fernandez, Conrad V ^c   Grundy, Paul E ^d   Leach, Stephen ^e   Marra, Marro A ^e   Brooks Wilson, Angela R ^e   Penninger, Josef ^f   Sorensen, Poul H B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c IWK HEALTH CENTRE   (Canada)

^d CROSS CANCER INSTITUTE   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; DNA; PROTEIN HACE1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 6Q; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 6; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; KIDNEY DEVELOPMENT; MOUSE; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANKYRIN REPEAT; CELL LINE, TUMOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; DNA METHYLATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMANS; INTRACELLULAR SPACE; KIDNEY; KIDNEY NEOPLASMS; MUTATION; RNA, MESSENGER; TRANSLOCATION, GENETIC; UBIQUITIN-PROTEIN LIGASES; WILMS TUMOR;

EID: 5744245556     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh215     Document Type: Article

References (63)

1. Rabbitts, T.H. (1994) Chromosomal translocations in human cancer. Nature, 372, 143-149.
2. Gnarra, J.R., Tory, K., Weng, Y., Schmidt, L., Wei, M.H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.M. et al. (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat. Genet., 7, 85-90.
3. Arai, E., Ikeuchi, T. and Nakamura, Y. (1994) Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2). Hum. Mol. Genet., 3, 937-939.
4. Rosty, C., Peter, M., Zucman, J., Validire, P., Delattre, O. and Aurias, A. (1998) Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22. Genes Chromosomes Cancer, 21, 82-89.
5. Versteege, I., Sevenet, N., Lange, J., Rousseau-Merck, M.F., Ambros, P., Handgretinger, R., Aurias, A. and Delattre, O. (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature, 394, 203-206.
6. Martin, E.S., Cesari, R., Pentimalli, F., Yoder, K., Fishel, R., Himelstein, A.L., Martin, S.E., Godwin, A.K., Negrini, M. and Croce, C.M. (2003) The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc. Natl Acad. Sci. USA, 100, 11517-11522.
7. Fernandez, C.V., Lestou, V.S., Wildish, J., Lee, C.L. and Sorensen, P.H. (2001) Detection of a novel t(6;15)(q21;q21) in a pediatric Wilms tumor. Cancer Genet. Cytogenet., 129, 165-167.
8. Dome, J.S. and Coppes, M.J. (2002) Recent advances in Wilms tumor genetics. Curr. Opin. Pediatr., 14, 5-11.
9. Bruce, C.K., Howard, P., Nowak, N.J. and Hoban, P.R. (2003) Molecular analysis of region t(5;6)(q21;q21) in Wilms tumor. Cancer Genet. Cytogenet., 141, 106-113.
10. Hoban, P.R., Cowen, R.L., Mitchell, E.L., Evans, D.G., Kelly, M., Howard, P.J. and Heighway, J. (1997) Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumor. J. Med. Genet., 34, 343-345.
11. Solis, V., Pritchard, J. and Cowell, J.K. (1988) Cytogenetic changes in Wilms' tumors. Cancer Genet. Cytogenet., 34, 223-234.
12. Utada, Y., Haga, S., Kajiwara, T., Kasumi, F., Sakamoto, G., Nakamura, Y. and Emi, M. (2000) Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3. Jpn J. Cancer Res., 91, 293-300.
13. Zhang, Y., Matthiesen, P., Harder, S., Siebert, R., Castoldi, G., Calasanz, M.J., Wong, K.F., Rosenwald, A., Ott, G., Atkin, N.B. et al. (2000) A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer, 27, 52-58.
14. Orphanos, V., McGown, G., Hey, Y., Thorncroft, M., Santibanez-Koref, M., Russell, S. E., Hickey, I., Atkinson, R.J. and Boyle, J.M. (1995) Allelic imbalance of chromosome 6q in ovarian tumors. Br. J. Cancer, 71, 666-669.
15. Hyytinen, E.R., Saadut, R., Chen, C., Paull, L., Koivisto, P.A., Vessella, R.L., Frierson, H.F., Jr and Dong, J.T. (2002) Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer, 34, 306-312.
16. Morelli, C., Karayianni, E., Magnanini, C., Mungall, A.J., Thorland, E., Negrini, M., Smith, D.I. and Barbanti-Brodano, G. (2002) Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene, 21, 7266-7276.
17. Pickart, C.M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem., 70, 503-533.
18. Huibregtse, J.M., Scheffner, M., Beaudenon, S. and Howley, P.M. (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl Acad. Sci. USA, 92, 2563-2567.
19. Weissman, A.M. (2001) Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol., 2, 169-178.
20. Bork, P. (1993) Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins, 17, 363-374.
21. Ingham, R.J., Gish, G. and Pawson, T. (2004) The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene, 23, 1972-1984.
22. Arcellana-Panlilio, M.Y., Egeler, R.M., Ujack, E., Pinto, A., Demetrick, D.J., Robbins, S.M. and Coppes, M.J. (2000) Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor. Genes Chromosomes Cancer, 29, 63-69.
23. Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol., 13, 775-784.
24. Izzi, L. and Attisano, L. (2004) Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene, 23, 2071-2078.
25. Horster, M.F., Braun, G.S. and Huber, S.M. (1999) Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol. Rev., 79, 1157-1191.
26. Pritchard-Jones, K. and Hastie, N.D. (1990) Wilms' tumor as a paradigm for the relationship of cancer to development. Cancer Surv. 9, 555-578.
27. Pritchard-Jones, K. (1999) The Wilms tumor gene, WT1, in normal and abnormal nephrogenesis. Pediatr. Nephrol., 13, 620-625.
28. Coppes, M.J. and Pritchard-Jones, K. (2000) Principles of Wilms' tumor biology. Urol. Clin. North Am., 27, 423-433, viii.
29. Knudson, A.J. and Strong, L.C. (1972) Mutation and cancer: a model for Wilms' tumor of the kidney. J. Natl Cancer Inst., 48 313-324.
30. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
31. Jain, P.K. (2003) Epigenetics: the role of methylation in the mechanism of action of tumor suppressor genes. Ann. NY Acad. Sci., 983, 71-83.
32. Nephew, K.P. and Huang, T.H. (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett., 190, 125-133.
33. Momparler, R.L. and Bovenzi, V. (2000) DNA methylation and cancer. J. Cell. Physiol., 183, 145-154.
34. Jones, P.A. and Taylor, S.M. (1980) Cellular differentiation, cytidine analogs and DNA methylation. Cell, 20, 85-93.
35. Ng, H.H., Feng, Q., Wang, H., Erdjument-Bromage, H., Tempst, P., Zhang, Y. and Struhl, K. (2002) Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev., 16, 1518-1527.
36. Iizuka, M. and Smith, M.M. (2003) Functional consequences of histone modifications. Curr. Opin. Genet. Dev., 13, 154-160.
37. Berger, S.L. (2002) Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev., 12, 142-148.
38. Friedlander, R., Jarosch, E., Urban, J., Volkwein, C. and Sommer, T. (2000) A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat. Cell Biol., 2, 379-384.
39. Russo, A.A., Tong, L., Lee, J.O., Jeffrey, P.D. and Pavletich, N.P. (1998) Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumor suppressor p16INK4a. Nature 395, 237-243.
40. Rice, J.C., Ozcelik, H., Maxeiner, P., Andrulis, I. and Futscher, B.W. (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis, 21, 1761-1765.
41. Nguyen, C., Liang, G., Nguyen, T.T., Tsao-Wei, D., Groshen, S., Lubbert, M., Zhou, J.H., Benedict, W.F. and Jones, P.A. (2001) Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst., 93, 1465-1472.
42. Srivastava, M., Hsieh, S., Grinberg, A., Williams-Simons, L., Huang, S.P. and Pfeifer, K. (2000) H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19. Genes Dev., 14, 1186-1195.
43. Ginjala, V., Holmgren, C., Ulleras, E., Kanduri, C., Pant, V., Lobanenkov, V., Franklin, G. and Ohlsson, R. (2002) Multiple cis elements within the Igf2/H19 insulator domain organize a distance-dependent silencer. A cautionary note. J. Biol. Chem., 277, 5707-5710.
44. Roessler, E., Ward, D.E., Gaudenz, K., Belloni, E., Scherer, S.W., Donnai, D., Siegel-Bartelt, J., Tsui, L.C. and Muenke, M. (1997) Cytogenetic rearrangements involving the loss of the Sonic Hedgehog gene at 7q36 cause holoprosencephaly. Hum. Genet., 100, 172-181.
45. Belloni, E., Muenke, M., Roessler, E., Traverso, G., Siegel-Bartelt, J., Frumkin, A., Mitchell, H.F., Donis-Keller, H., Helms, C., Hing, A.V. et al. (1996) Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat. Genet., 14, 353-356.
46. Grewal, S.I. and Moazed, D. (2003) Heterochromatin and epigenetic control of gene expression. Science, 301 798-802.
47. Noma, K., Allis, C.D. and Grewal, S.I. (2001) Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science, 293, 1150-1155.
48. Richards, E.J. and Elgin, S.C. (2002) Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell, 108, 489-500.
49. Yoshida, B.A., Sokoloff, M.M., Welch, D.R. and Rinker-Schaeffer, C.W. (2000) Metastasis-suppressor genes: a review and perspective on an emerging field. J. Natl Cancer Inst., 92, 1717-1730.
50. Sakamoto, K.M. (2002) Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies. Mol. Genet. Metab., 77, 44-56.
51. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75 495-505.
52. Yang, Y., Li, C.C. and Weissman, A.M. (2004) Regulating the p53 system through ubiquitination. Oncogene, 23, 2096-2106.
53. Tognon, C., Knezevich, S.R., Huntsman, D., Roskelley, C.D., Melnyk, N., Mathers, J.A., Becker, L., Carneiro, F., MacPherson, N., Horsman, D. et al. (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2, 367-376.
54. Tognon, C.E., Kirk, H.E., Passmore, L.A., Whitehead, I.P., Der, C.J. and Kay, R.J. (1998) Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol. Cell. Biol., 18, 6995-7008.
55. Anderson, C.L. and Brown, C.J. (2002) Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation. Hum. Genet., 110, 271-278.
56. Goodfellow, P.J., Mondello, C., Darling, S.M., Pym, B., Little, P. and Goodfellow, P.N. (1988) Absence of methylation of a CpG-rich region at the 5′ end of the MIC2 gene on the active X, the inactive X, and the Y chromosome. Proc. Natl Acad. Sci. USA, 85 5605-5609.
57. Sarkar, S., Roy, B.C., Hatano, N., Aoyagi, T., Gohji, K. and Kiyama, R. (2002) A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma. J. Biol. Chem. 277, 36585-36591.
58. Luo, R.X., Postigo, A.A. and Dean, D.C. (1998) Rb interacts with histone deacetylase to repress transcription. Cell, 92, 463-473.
59. Ewing, B. and Green, P. (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res., 8, 186-194.
60. Ewing, B., Hillier, L., Wendl, M.C. and Green, P. (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res., 8, 175-185.
61. Nickerson, D.A., Tobe, V.O. and Taylor, S.L. (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucl. Acids Res. 25, 2745-2751.
62. Gordon, D., Abajian, C. and Green, P. (1998) Consed: a graphical tool for sequence finishing. Genome Res., 8, 195-202.
63. Evdokimova, V., Ruzanov, P., Imataka, H., Raught, B., Svitkin, Y., Ovchinnikov, L.P. and Sonenberg, N. (2001) The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J., 20, 5491-5502.